Evidence map›Paper›PMID 29351187›Full record

ArticleInternational journal of environmental research and public health2018

High Proportions of Multidrug-Resistant Acinetobacter spp. Isolates in a District in Western India: A Four-Year Antibiotic Susceptibility Study of Clinical Isolates.

Ingvild Odsbu, Smita Khedkar, Uday Khedkar, Sandeep S Nerkar, Ashok J Tamhankar, Cecilia Stålsby Lundborg

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Multidrug-ResistantInfection and drug resistance · 2020
    Article
  5. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  6. A 2-Year Single-Centre Audit on Antibiotic Resistance ofAntibiotics (Basel, Switzerland) · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ingvild OdsbuDepartment of Public Health Sciences, Karolinska Institutet, 17177 Stockholm, Sweden. ingvild.odsbu@ki.se.ORCID 0000-0002-5337-8619
Smita KhedkarBac-Test Laboratory, College Road, Nashik 422005, Maharashtra, India. mail@bactestlab.com.
Uday KhedkarBac-Test Laboratory, College Road, Nashik 422005, Maharashtra, India. udayk_nsk@sancharnet.in.
Sandeep S NerkarDepartment of Public Health Sciences, Karolinska Institutet, 17177 Stockholm, Sweden. san.ner1978@gmail.com.
Ashok J TamhankarDepartment of Public Health Sciences, Karolinska Institutet, 17177 Stockholm, Sweden. ejetee@gmail.com.ORCID 0000-0003-0731-1680
Cecilia Stålsby LundborgDepartment of Public Health Sciences, Karolinska Institutet, 17177 Stockholm, Sweden. cecilia.stalsby.lundborg@ki.se.ORCID 0000-0001-6525-1861

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of the study was to determine the proportions of multidrug-resistant (MDR)

Indexed as

AcinetobacterAnti-Bacterial Agentsbeta-LactamasesDisk Diffusion Antimicrobial TestsDrug Resistance, Multiple, BacterialFluoroquinolonesHumansIndiaMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-LactamasesFluoroquinolonesAcinetobacterantibacterial susceptibility testingantibiotic resistanceIndiamultidrug resistance

Identifiers

PMID29351187
PMCPMC5800252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.